Dexcom (DXCM) Other Operating Expenses (2010 - 2022)

Dexcom (DXCM) has 7 years of Other Operating Expenses data on file, last reported at -$5.7 million in Q4 2022.

• On a quarterly basis, Other Operating Expenses fell 106.72% year-over-year to -$5.7 million in Q4 2022; TTM through Sep 2023 was -$5.7 million, a 106.3% decrease from a year earlier, with the FY2021 full-year figure at $87.1 million, up 3384.0% from the prior year.
• Other Operating Expenses for Q4 2022 stood at -$5.7 million, down from $1.8 million in the prior quarter.
• Over the last five years, Other Operating Expenses for DXCM reached as high as $217.7 million in Q4 2018 and fell as low as -$5.7 million in Q4 2022.
• Historically, Other Operating Expenses has averaged $30.7 million across 5 years, with a median of $1.8 million in 2022.
• Across the five-year window, Other Operating Expenses jumped 4194304000000100.0% in 2020 and sank 106.72% in 2022, its largest moves.
• Year by year, Other Operating Expenses stood at $217.7 million in 2018, then tumbled by 100.0% to -$0.0 in 2019, then soared by 4194304000000100.0% to $2.5 million in 2020, then surged by 3292.0% to $84.8 million in 2021, then sank by 106.72% to -$5.7 million in 2022.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$5.7 million in Q4 2022, $1.8 million in Q3 2022, and $1.9 million in Q2 2022.